|
|
| 0.0498 Data as of Apr 16 |  +0.0034 / +7.33%Today’s Change | 0.02 Today|||52-Week Range 0.16 | -15.59% Year-to-Date |
| Previous close | 0.05 |
| Today’s open | 0.05 |
| Day’s range | 0.05 - 0.05 |
| Volume | 2,800 |
| Average volume (3 months) | 74,128 |
| Market cap | $19.3M |
| Dividend yield | -- |
| Earnings growth (last year) | 0.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -10.14% |
| P/E ratio | NM |
| Price/Sales | 3.15 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| FPMIFluoroPharma Medical... | -0.02 | -2.70% |
| TROVUTrovagene Inc | 0.00 | 0.00% |
| BMRABiomerica Inc | +0.02 | +2.50% |
| GALTUGalectin Therapeutic... | 0.00 | 0.00% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $6.8M |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Medical Specialties |
President, CEO, Secretary & Director Steve T. Laflin |
Chief Financial Officer & Secretary Laurie A. McKenzie-Carter |
Corporate headquarters Idaho Falls, Idaho |
.
